cvot tirzepatide SURPASS-CVOT shows delivers comparable cardiovascular safety to dulaglutide in patients with type 2 diabetes and established ASCVD, reinforcing the shift toward therapies that optimize whole cardiometabolic systems. As outcome datasets grow Systolic blood pressure reduction with

Signs of bowel obstruction, including persistent vomiting, inability to pass gas, and severe bloating, are emergencies as well

Ready to feel revitalized and less fatigued

The activation of GIP receptors by retatrutide promotes glucose dependent insulinotropic polypeptide insulin secretion and insulin release in response to food intake, significantly improving glycemic control

We offer both in-person and virtual appointments, so you can work toward your weight loss goals in a setting thats most comfortable for you

The goal isnt dramatic weight reduction, but gentle recalibration a quieter support for patients who: Are already within a healthy weight range but struggle with subtle hormonal weight fluctuations Experience puffiness or facial bloating unrelated to diet Want to reduce fat while retaining or building muscle mass Want to enhance treatments for hormonal challenges like PCOS and autoimmune challenges like lymphadema Prefer a metabolically sound approach to aesthetic maintenance as they age This strategy may also appeal to patients seeking preventative aging support